Plandai Biotechnology Inc (PLPL)

[highlandernew]

03/12/2018 (GLOBENEWSWIRE) PLPL Returns to Active SEC Reporting Status?

"Plandai Biotechnology Engages Hayden IR to Develop Comprehensive Investor Relations Program

Focused on Increasing Awareness and Enhancing Shareholder Value

Plans to Return to Active SEC Reporting Status

LONDON, UNITED KINGDOM, March 12, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, today announced that it has retained Hayden IR, a national investor relations consulting firm, to implement a strategic investor relations program grounded in best practices. Hayden IR will work to raise Plandai’s visibility within the investment community by strengthening its relationships and increasing awareness with the goal of ultimately enhancing shareholder value.

“We are encouraged by our development and recent traction we have made over the past few months and believe we are well positioned to penetrate market opportunities and ramp our sales in the animal phytogenics premixes, dietary supplements and diabetes industries,” said Callum Cottrell-Duffield, Plandai’s Chief Operating Officer. “The available opportunities within our targeted markets have increased and created a solid pipeline of projects. As we look to return to an active reporting status with the SEC, the Board and management believed it was an appropriate time to retain a more proactive strategic investor relations firm to help us reach new potential investors and effectively communicate our investment thesis. We are confident that throughout their national footprint, Hayden IR will help us more effectively communicate our accelerated growth strategy, business objectives and corporate milestones to a wider audience of sophisticated investors.”

Hayden IR is a highly regarded investor relations consulting firm known for its ability to connect under-followed and undervalued emerging growth companies with sophisticated institutional investors, buy-side and sell-side analysts, retail brokerage firms and accredited individual investors. Leveraging decades of cumulative experience, Hayden IR develops strategies to help clients effectively communicate with the investment community and works to increase their exposure through targeted outreach and transparent positioning. Hayden IR helps public companies deliver the right message to the right audience. Over time, Hayden IR helps its clients navigate up the Wall Street value chain and to help them secure a reasonable valuation by broadening their audience, expanding institutional ownership and ensuring clear, consistent communication with the public."

http://globenewswire.com/news-release/2018/03/12/1420541/0/en/Plandai-Biotechnology-Engages-Hayden-IR-to-Develop-Comprehensive-Investor-Relations-Program.html

What are your thoughts about this?